BioNexus Gene Lab (BGLC) Cash from Financing Activities (2018 - 2026)
BioNexus Gene Lab (BGLC) posted Cash from Financing Activities of $59709.0 for Q1 2026, down 77.6% sequentially from $266544.0 in Q4 2025, and up 7042.91% YoY from $835.92 in Q1 2025.
BioNexus Gene Lab (BGLC) Cash from Financing Activities (2018 - 2026) Analysis & Trends
BioNexus Gene Lab has reported Cash from Financing Activities for 9 years, with the latest figure at $59709.0 in Q1 2026.
- Quarterly Cash from Financing Activities rose 7042.91% year-over-year to $59709.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359410.0 (up 1609.17% YoY) and the FY2025 annual result came in at $298841.0, up 7418.01% from the prior year.
- Cash from Financing Activities retreated to $59709.0 in Q1 2026 per BGLC's latest filing, from $266544.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $5.7 million in Q3 2023 and troughed at -$142387.0 in Q4 2024.
- A 5-year average of $421602.0 and a median of $13035.0 in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 331172.47% in 2023, then slumped 126.78% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$2273.0 in 2022, then jumped by 23493.44% to $531733.0 in 2023, then plunged by 126.78% to -$142387.0 in 2024, then soared by 287.2% to $266544.0 in 2025, then sank by 77.6% to $59709.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $59709.0, $266544.0, and $34187.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 225.67 Bn | 220.77 Bn | 4.43 Bn | 321.00 Mn |
| 2 | Sherwin Williams | 84.74 Bn | 84.44 Bn | 3.34 Bn | -1.06 Bn |
| 3 | Ecolab | 78.90 Bn | 73.77 Bn | 1.95 Bn | - |
| 4 | Air Products & Chemicals | 68.19 Bn | 67.21 Bn | 1.04 Bn | -285.30 Mn |
| 5 | Ppg Industries | 25.36 Bn | 23.77 Bn | 1.81 Bn | -444.00 Mn |
| 6 | Chemical & Mining Co Of Chile | 23.48 Bn | 19.61 Bn | 778.60 Mn | - |
| 7 | LyondellBasell Industries | 21.91 Bn | 19.28 Bn | 2.04 Bn | -233.00 Mn |
| 8 | International Flavors & Fragrances | 21.51 Bn | 20.94 Bn | 853.00 Mn | -264.00 Mn |
| 9 | DuPont de Nemours | 18.83 Bn | 17.09 Bn | 639.00 Mn | -381.00 Mn |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 | 13,607.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,709.00 |
| Mar 31, 2026 | 59,709.00 |
| Dec 31, 2025 | 266,544.00 |
| Dec 31, 2025 | 266,544.00 |
| Sep 30, 2025 | 34,187.00 |
| Sep 30, 2025 | 34,187.00 |
| Jun 30, 2025 | -1,030.00 |
| Jun 30, 2025 | -1,030.00 |
| Mar 31, 2025 | -860.00 |
| Mar 31, 2025 | -860.00 |
| Dec 31, 2024 | -142,387.00 |
| Dec 31, 2024 | -142,387.00 |
| Sep 30, 2024 | -55,982.00 |
| Sep 30, 2024 | -55,982.00 |
| Jun 30, 2024 | 175,414.00 |
| Jun 30, 2024 | 175,414.00 |
| Mar 31, 2024 | 26,930.00 |
| Mar 31, 2024 | 26,930.00 |
| Dec 31, 2023 | 531,733.00 |
| Dec 31, 2023 | 531,733.00 |